| adult stem cells |
001, 159 |
| embryonic stem cells |
001, 012, 033, 044, 129, 152, 159 |
| hematopoietic stem cells |
001, 012 |
| induced pluripotent stem cells |
001, 159 |
| mesenchymal stem cells |
001, 012, 050, 129, 134 |
| neural stem cells. |
001 |
| stem cell |
007, 019, 033, 039, 112, 129, 134 |
| stem cell cure |
007 |
| stem cell isolation. |
007 |
| longterm hematopoietic stem cells |
012 |
| short-term hematopoietic stem cells. |
012 |
| exosomes |
019 |
| extracellular vesicles |
019 |
| mesenchymal stem cell |
019 |
| microvesicle. |
019 |
| 3d cell culture |
033 |
| extracellular matrix |
033 |
| organoids. |
033 |
| stem cell treatments |
039 |
| health technology |
039 |
| innovation. |
039 |
| adult stem cell |
044 |
| lncrna |
044 |
| microrna |
044 |
| non-coding rna |
044 |
| self-renewal |
044 |
| stem cell. |
044, 081, 101, 164 |
| cellular therapy |
050 |
| stem cells |
050, 060, 069, 125 |
| somatic cells |
050 |
| therapeutics . |
050 |
| beta cells |
060 |
| diabetes mellitus |
060 |
| stem cell therapy |
060, 159 |
| embryonic stem cell. |
060 |
| autoimmune diseases |
069 |
| immune response |
069 |
| immune system |
069 |
| treatment. |
069 |
| anti-aging |
081 |
| dermatology |
081 |
| dermocosmetics |
081 |
| alzheimer’s disease |
088 |
| amyotrophic lateral sclerosis |
088 |
| huntington's disease |
088 |
| neurodegenerative disorders |
088 |
| parkinson’s disease |
088 |
| stem cells. |
088 |
| acute respiratory distress syndrome |
101 |
| cytokine storm |
101 |
| immunotherapy |
101 |
| sars-cov-2 |
101 |
| sepsis |
101 |
| bone defect |
112 |
| cartilage degeneration |
112 |
| regeneration |
112 |
| spinal cord injury |
112 |
| tendon injury. |
112 |
| surgery |
125 |
| treatment |
125 |
| repair |
125 |
| regeneration. |
125 |
| adipose-derived stem cells |
129 |
| bone marrow mesenchymal stem cells |
129 |
| plastic surgery. |
129 |
| intervertebral disk degeneration |
134 |
| osteoarthritis |
134 |
| tendon ligament injury |
134 |
| veterinary medicine. |
134 |
| cancer |
144, 152 |
| cancer stem cells |
144 |
| cancer treatment |
144 |
| tumor-initiating cells. |
144 |
| pluripotent stem cells |
152 |
| stem cell therapy. |
152 |
| therapeutic approach |
159 |
| transplantation parameters. |
159 |
| cloning |
164 |
| ethics |
164 |
| genetic engineering |
164 |
| human embryonic stem cell |
164 |
| regenerative medicine |
164 |
